Glycosaminoglycans in cats with FLUTD
Bertie is an 8 year old male neutered domestic short haired cat who has suffered long term problems with non-obstructive feline lower urinary tract disease (FLUTD). He is already on dietary and environmental control and his owners have tried other treatments without any success in reducing his clinical signs. His owners are keen to try any other treatments available and you wonder if an oral glycosaminoglycan supplement you heard about on a CPD course would help reduce Bertie's clinical signs…
3-Part Question (PICO)
In [cats with non-obstructive lower urinary tract disease] does [the use of oral glycosaminoglycans or their precursors compared to placebo] [reduce clinical signs]?
Search Strategy and Summary of Evidence
MEDLINE(R) In-Process & Other Non-Indexed Citations and MEDLINE(R) 1946 to Present using the OVID interface
(cat.mp. OR cats.mp. OR feline.mp. OR felines.mp. OR felis.mp. OR exp Cats/)
(FLUTD.mp. OR cystitis.mp. OR lower urinary tract.mp. OR urological syndrome.mp. OR urologic syndrome.mp. OR FUS.mp. OR FIC.mp. OR exp urologic diseases/)
(GAG.mp. OR GAGs.mp. OR glycosaminoglycan.mp. OR glycosaminoglycans.mp. OR pentosan polysulphate.mp. OR pentosan polysulfate.mp. OR elmiron.mp. OR glucosamine.mp. OR glucosamines.mp. OR cystaid.mp. OR cystease.mp. OR exp Glycosaminoglycans/ OR exp Pentosan Sulfuric Polyester/)
CAB Abstracts 1910 to Present using the OVID interface
(cat.mp. OR cats.mp. OR feline.mp. OR felines.mp. OR felis.mp. OR exp cats/)
(FLUTD.mp. OR cystitis.mp. OR lower urinary tract.mp. OR urological syndrome.mp. OR urologic syndrome.mp. OR FUS.mp. OR FIC.mp. OR exp urinary tract diseases/)
(GAG.mp. OR GAGs.mp. OR glycosaminoglycan.mp. OR glycosaminoglycans.mp OR pentosan polysulphate.mp. OR pentosan polysulfate.mp. OR elmiron.mp. OR glucosamine.mp. OR glucosamines.mp. OR cystaid.mp. OR cystease.mp. OR exp glycosaminoglycans/ OR exp glucosamine/ OR exp pentosans/)
- 18 papers found in MEDLINE search
- 17 papers excluded as they don't meet the PICO question
- 0 papers excluded as they are in a foreign language
- 0 papers excluded as they are review articles/in vitro research/conference proceedings
- 1 total relevant papers from MEDLINE
- 27 papers found in CAB search
- 15 papers excluded as they don't meet the PICO question
- 0 papers excluded as they are in a foreign language
- 11 papers excluded as they are review articles/in vitro research/conference proceedings
- 1 total relevant papers from CAB
Total relevant papers1 relevant papers from both MEDLINE and CAB Abstracts
CommentsA second paper by Panchaphanpong et al. (2011) was identified, but excluded as the study examined blood and urine parameters only and did not look at clinical efficacy.
Summary of Evidence
Gunn-Moore & Shenoy (2004), United Kingdom
|Title:||Oral glucosamine and the management of feline idiopathic cystitis|
|Patient group:||Forty cats visiting a referral practice with a history of recurrent dysuria, pollakiuria and haematuria. Twenty cats received 125mg N-acetyl glucosamine daily by mouth and twenty cats received placebo daily by mouth for 6 months.|
|Study Type:||Randomised controlled trial|
- No significant differences were noted between the two groups in terms of mean health score, monthly clinical score or the mean number of days with clinical signs
- Health score of both groups improved significantly over the study
- Urine specific gravity at start of trial was higher than at the end of the study in cats of both groups
- Recurrence occured in 26 (65%) of the 40 cats
- Two cats (both in the placebo group) were euthanased during the study, due to severe recurrent urethral obstruction
- All cases were referred to a specialist centre; therefore these cases may not representative of the general population.
- The sample size was relatively small (n=40); however the chances of a Type II error (false negative) were calculated to be less than 10%.
- The raw data are not present and missing data/loss to follow up are not fully described.
- The methods are not described in sufficient detail to allow the study to be repeated.
- Subjective scores were used which may lead to measurement bias; no validation/reliability studies of the scoring systems used were reported.
There are limited data on the effectiveness of oral glycosaminoglycans or their precursors for the treatment of idiopathic cystitis, with no significant differences in clinical signs identified between the treatment and placebo groups. The limited number of patients means that the study may have been underpowered, so it is possible that any actual differences between the two groups were not identified.
The BETs on this website are a summary of the evidence found on a topic and are not clinical guidelines. It is the responsibility of the individual veterinary surgeon to ensure appropriate decisions are made based on the specific circumstances of patients under their care, taking into account other factors such as local licensing regulations. Read small print
Gunn-Moore DA, Shenoy CM, (2004). Oral glucosamine and the management of feline idiopathic cystitis. Journal of Feline Medicine and Surgery 6: 219-25.
Panchaphanpong J, Asawakarn T, Pusoonthornthum R, (2011). Effects of oral administration of N-acetyl-D-glucosamine on plasma and urine concentrations of glycosaminoglycans in cats with idiopathic cystitis. American Journal of Veterinary Research 72: 843-50
About this BET
A BET is a simple method of searching for and appraising evidence around a very specific clinical situation.
BETs don’t tell you what to do, they tell you about the evidence on a certain topic.
Not a Vet?
This website has been designed to help vets use the best, most relevant, up to date science when they make decisions about their patients.